Haemopoietic growth factors, the cell cycle of acute myeloblastic leukaemia progenitors and sensitivity to cytosine arabinoside

Leukemia and Lymphoma

Volumn 23, Issue 5-6, 1996, Pages 467-472

  Smith, M A ^a   Smith, J G ^a   Pallister, C J ^b   Singer, C R J ^a  

^a ROYAL UNITED HOSPITALS BATH NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF THE WEST OF ENGLAND   (United Kingdom)

Author keywords

AML; CFU GM; Cytosine arabinoside; rh cytokines; S phase

Indexed keywords

CYTARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR; INTERLEUKIN 3;

ACUTE MYELOBLASTIC LEUKEMIA; CELL CYCLE; DRUG SENSITIVITY; HEMATOPOIESIS; LEUKEMIA CELL; PRIORITY JOURNAL; REVIEW;

EID: 0030465011     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199609054855     Document Type: Review

References (36)

1. te Boekhorst, P. A. W., Lowenberg, B., Vlastuin, M. and Sonneveld, P. (1993) Enhanced chemosensitivity of clonogenic blasts from patients with acute myeloid leukemia by G-CSF, IL-3 or GM-CSF stimulation. Leukemia, 7(8), 1191-1198.
2. Aglietta, M., Piacibello, P., Pasquino, P., Sanavio, F., Stacchini, A., Volta, C., Monteverde, A., Fubini, L., Morelli, S. and Severino, A. (1994) Rationale for the use of granulocyte-macrophage colony stimulating factor in oncology. Seminars in Oncology, 21(6), 5-9.
3. Heil, G., Chadid, L., Hoezler, D., Speipelt, G., Mitrou, P., Huber, C., Kolbe, K., Mertlesmann, A. et al. (1995) GM-CSF in a double-blind randomized, placebo controlled trial in therapy of adult patients with de novo acute myeloid leukemia (AML). Leukemia, 9, 3-9.
4. Yamada, K., Furusawa, S., Saito, K., Waga, K., Koike, T. and al, e. (1995) Concurrent use of granulocyte colony-stimulating factor with low-dose cytosine arabinoside and alarubicin for previously treated acute myelogenous leukemia: a pilot study. Leukemia, 9, 10-14.
5. Muhm, M., Andreef, M. and Geissler, K. (1989) rh GM-CSF in combination with chemotherapy-a new strategy in the therapy of acute myeloid leukemia. Blood, 74, (Suppl. 1), 117a.
6. Bettelheim, P., Valent, P., Andreef, M., Tafuri, A , Haimi, J., Gorischek, C., Muhm, M. et al (1991) Recombinant human granulocyte-macrophage colony stimulating factor in combination with standard induction chemotherapy in de novo acute myeloid leukemia. Blood, 77, 700-711.
7. Cannistra, S., Di Carlo, J., Groshek, P., Kanakura, Y., Berg, D., Mayer, R. J. and Griffin, J. D. (1991) Simultaneous administration of granulocyte-macrophage colony stimulating factor and cytosine arabinoside for the treatment of relapsed acute myeloid leukemia. Leukemia, 5, 230-238.
8. Estey, E., Hall, P., Kantarjian, H., O'Brien, S , Koller, C. A., Beran, M., Gutterman, J., Deisseroth, A. and Keating, M. (1992) Treatment of newly diagnosed acute myeloid leukemia with granulocyte-macrophage colony stimulating factor (GM-CSF) before and during continuous-infusion high-dose ara-c and daunorubicin: comparison to patients treated without GM-CSF. Blood, 79, 2246-2255.
9. Archimbaud, E., Fenaux, P., Reiffers, J., Cordonnier, C., Leblond, V., Travade, P., Troussard, X. et al (1993) Granulocyte-macrophage-colony-stimulating factor in association to timed-sequential chemotherapy with mitoxantrone, etoposide and cytarabine for refractory myelogenous leukemia. Leukemia, 7(3), 372-377.
10. Puntous, M., Lacombe, F., Dumain, P., Marit, G., Cony-Makhoul, P , Belloc, F., Boiron, J. M., Laurent, G., Bernard, P. H. and Reiffers, J. (1993) Treatment of relapsed acute myeloid leukemia using GM-CSF before intensive chemotherapy. Leukemia and Lymphoma, 12, 95-102.
11. Ohno, R , Naoe, T., Kanamura, A., Yoshida, M., Hiroaki, A , Kobayashi , I., Veda, T., et al. (1994) A double-blind controlled study of granulocyte colony-stimulating factor started two days before induction chemotherapy in refractory acute myeloid leukemia. Blood, 83, 2086-2092.
12. Delwel, R., Dorssers, L., Touw, I., Wagemaker, G. and Lowenberg, B (1987) Human recombinant multilineage colony stimulating factor (interleukin 3): stimulator of acute myelocytic leukaemia progenitor cells in vitro. Blood, 70, 333-338.
13. Lowenberg, B., Salem, M. and Delwel, R. (1988) Effects of recombinant multi-CSF, GM-CSF, G-CSF and M-CSF on the proliferation and maturation of human AML in vitro. Blood Cells, 14, 539.
14. Delwel, R., Salem, M., Pellens, C , Dorssers, L., Wagemaker, G., Clark, S. C. and Lowenberg, B. (1988) Growth regulation of human myeloid leukemia: Effects of five recombinant hematopoietic factors in a serum-free culture system. Blood, 72, 1944-1949
15. Strife, A , Lambek, C., Wisniewski, D., Gulati, S., Gasson, J. C., Golde, D. W., Welte, K., Gabrilove, J. L. and Clarkson, B. (1987) Activities of four purified growth factors on highly enriched human haematopoietic progenitor cells. Blood, 69, 1508-1523.
16. Bot, F. J., Eijk, L. v., Schipper, P. and Lowenberg, B. (1989) Effects of human interleukin-3 on granulocytic colony forming cells in human bone marrow. Blood, 73, 115-1160.
17. Metcalf, D. (1990) The colony stimulating factors:discovery, development and clinical applications. Cancer, 65, 1285-1295.
18. Smith, M. A., Singer, C. R. J., Pallister, C. J. and Smith, J G. (1995) The effect of haemopoietic growth factors on the cell cycle of AML progenitors and their sensitivity to cytosine arabinoside "in vitro". British Journal of Haematology, 90, 767-773
19. Smith, M. A., Smith, J. G., Provan, A. B. and Singer, C. R. J. (1994) The effect of rh-cytokines on the sensitivity of normal human CFU-GM progenitors to Ara-C and on the S-phase activity of light density human bone marrow cells. Leukemia Research, 18, 105-110.
20. Pietsch, T., Kyass, U., Steffens, U., Yakisan, E., Hadam, M. R., Ludwic, W. D., Zsebo, K. and Wette, C. (1992) Effects of stem cell factor (c-kit ligand) on proliferation of myeloid leukemia cells; heterogeneity in response and synergy with other hematopoietic growth factors. Blood, 80, 1199-1206.
21. Budel, L. M., Delwel, R., Buitenen, C., Hoogerbrugge, H. and Lowenberg, B. (1993) Effects of mast cell growth factor on acute myeloid leukemia cells in vitro: effects of combinations with other cytokines. Leukemia, 7(3), 426-434
22. Hoffman, R., Tong, J., Brandt, J., Traycoff, C., Bruno, E., McGuire, B W., Gordon, M. S., McNiece, I. and Srour, E. F. (1993) The in vitro and in vivo effects of stem cell factor on human hematopoiesis. Stem Cells, 11 (suppl. 2), 76-82.
23. Mc Niece, I. K. and Zsebo, K. M. (1993) The role of stem cell factor in the haematopoietic system. Cancer Investigation, 11(b), 724-729.
24. Simmons, P. J., Aylett, G. W., Nivtta, S., To, L. B., Juttner, C. A. and Ashman, K. L (1994) c-kit is expressed by primitive human hematopoietic cells that give rise to colony forming cells in stroma-dependent or cytokine-supplemented culture. Experimental Hematology, 22, 157-165.
25. Bhalla, K., Birkhofer, M., Arlin, Z., Grant, S., Lutzky, J. and Graham, G. (1988) Effect of recombinant GM-CSF on the metabolism of cytosine arabinoside in normal and leukemic human marrow cells. Leukemia, 2(12), 810-813.
26. Gibson, F. M., Scopes, J., Daly, S., Ball, S. E. and Gordon-Smith, E. C. (1994) In vitro response of normal and aplastic anaemia bone marrow to mast cell growth factor and in combination with granulocyte-macrophage colony-stimulating factor and interleukin-3. Experimental Haematology, 22(3), 302-312.
27. Carlesso, N., Pregno, P., Bresso, P., Gallo, E., Pileri, A., Zsebo, K. and Ferrero, D. (1992) Human recombinant stem cell factor stimulates in vitro proliferation of acute myeloid leukemia cells and expands the clonogenic pool. Leukemia, 6(7), 642-648.
28. Brandt, J., Briddell, R. A., Srour, E. F., Leemhuis, T. B. and Hoffman, R. (1992) Role of c-kit ligand in expansion of human haemopoietic progenitor cells Blood, 79(3), 634-641.
29. Hoang, T., Nara, N., Wang, G., Clark, S., Minden, M. D. and McCulloch, E. A. (1986) Effects of recombinant GM-CSF on the blast cells of acute myeloblastic leukemia. Blood, 68, 313-316.
30. Mc Culloch, E. A., Kelleher, C. A , Mijuadi, J., Wang, G., Cheng, G. Y. C., Minden, M D. and Curtis, J. E. (1988) Heterogeneity in acute myeloblastic leukemia. Leukemia, 2 (suppl. 12), 38s-39s.
31. Ferrero, D., Carlesso, N., Pregno, P., Gallo, E. and Pileri, A. (1992) Self renewal inhibition of acute myeloid leukemia clonogenic cells by biological induces of differentiation. Leukemia, 6, 100-106.
32. Capizi, R. L., Yang, J. L , Cheng, T., Bjornsson, T., Sahasrabudhe, D , Tan, R. S. and Chen, Y. C. (1983) Alteration of the pharmacokinetics of high dose ara C by its metabolite, high ara U in patients with acute leukemia. Journal of Clinical Oncology, 1, 763-771.
33. Plunkett, W., Lilie Mark, J. O., Estey, E and Keating, M. J. (1987) Saturation of ara CTP accumulation during high-dose ara C therapy: pharmacologic rationale for intermediate-dose ara C. Seminars in Oncology, 14, 159-166.
34. White, J. C., Rathmell, J. P. and Cappizzi, R. L. (1987) Membrane transport influences the rate of accumulation of cytosine arabinoside in human leukemia cells. Journal of Clinical Investigation, 79, 380-387.
35. Rathmell, J. P., Capizzi, R. L. and Craig, J. (1986) Membrane phospholipid as a possible target for ara-C in human leukemia. Proceedings of the American Society for Clinical Oncology, 5, 47.
36. Bhalia, K., Tourkina, E., Huang, Y., Tang, C., Mahoney, M E. and Ibrado, A M. (1993) Effect of hemopoietic growth factors G-CSF and pIXY 321 on the activity of high dose ARA-C in human myeloid leukemia cells. Leukemia and Lymphoma, 10 (suppl.), 123-131.